GENE ONLINE|News &
Opinion
Blog

Deals
Licensing RESILIENCE
Resilience, Harvard University Ink 5-Year Strategic R&D Alliance Leveraging Biomedical Innovation for a Resilient Tomorrow
2021-10-16
Licensing Gene Therapy
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
M&A Pain Management
Pacira Acquires Flexion for $425 Million to Expand Non-Opioid Painkiller Portfolio
2021-10-12
Licensing Gene Therapy
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Licensing Gene Therapy
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
IPO DNA Sequencing
Oxford Nanopore Soars on London Market Debut
2021-10-05
Licensing Cancer Immunotherapy
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
M&A Gene Therapy
Amicus Therapeutics Spins Off Its Gene Therapy Unit in a SPAC Deal
2021-10-02
Licensing Mesenchymal Stem Cell
Wanting In on US Market, Cynata Taps Fujifilm to Advance Stem Cell Products
2021-10-01
M&A Cardiovascular Disease
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
M&A Amyloidosis
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
Licensing cGVHD
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
IPO SPAC
Prenetics To Become First Unicorn from Hong Kong To Go Public via SPAC Merger
2021-09-27
IPO COVID-19
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
1 … 27 28 29 30 31 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top